Loading...
Zynex, Inc.
ZYXI•NASDAQ
Healthcare
Medical - Distribution
$2.69
$0.03(1.13%)
Zynex, Inc. (ZYXI) Financial Performance & Statements
Review Zynex, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.36%
↑ 4.36%
Operating Income Growth
-44.43%
↓ 44.43%
Net Income Growth
-69.24%
↓ 69.24%
Operating Cash Flow Growth
-28.36%
↓ 28.36%
Operating Margin
-4.43%
↓ 4.43%
Gross Margin
77.67%
↑ 77.67%
Net Profit Margin
-4.30%
↓ 4.30%
ROE
-23.70%
↓ 23.70%
ROIC
-8.53%
↓ 8.53%
Zynex, Inc. (ZYXI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Zynex, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $45.97M | $49.97M | $49.88M | $46.53M |
| Cost of Revenue | $9.98M | $10.18M | $9.97M | $9.30M |
| Gross Profit | $35.99M | $39.79M | $39.91M | $37.23M |
| Gross Profit Ratio | $0.78 | $0.80 | $0.80 | $0.80 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $36.55M | $35.99M | $37.69M | $36.71M |
| Operating Expenses | $36.55M | $35.99M | $37.69M | $36.71M |
| Total Costs & Expenses | $46.54M | $46.16M | $47.66M | $46.006M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $615000.00 | $625000.00 | $630000.00 | $512000.00 |
| Depreciation & Amortization | $0.00 | $1.11M | $1.16M | $1.10M |
| EBITDA | -$563000.00 | $4.91M | $3.38M | $1.62M |
| EBITDA Ratio | -$0.01 | $0.10 | $0.07 | $0.03 |
| Operating Income | -$563000.00 | $3.80M | $2.23M | $525000.00 |
| Operating Income Ratio | -$0.01 | $0.08 | $0.04 | $0.01 |
| Other Income/Expenses (Net) | -$615000.00 | -$625000.00 | -$611000.00 | -$512000.00 |
| Income Before Tax | -$1.18M | $3.18M | $1.61M | $13000.00 |
| Income Before Tax Ratio | -$0.03 | $0.06 | $0.03 | $0.00 |
| Income Tax Expense | -$563000.00 | $795000.00 | $398000.00 | $3000.00 |
| Net Income | -$615000.00 | $2.38M | $1.22M | $10000.00 |
| Net Income Ratio | -$0.01 | $0.05 | $0.02 | $0.00 |
| EPS | -$0.02 | $0.07 | $0.04 | $0.00 |
| Diluted EPS | -$0.02 | $0.07 | $0.04 | $0.00 |
| Weighted Avg Shares Outstanding | $31.89M | $31.77M | $31.76M | $32.34M |
| Weighted Avg Shares Outstanding (Diluted) | $32.19M | $32.09M | $32.20M | $32.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan